Akira Nakagawara

发表

Semiconductor memory device having a Adressübergangsabfühlschaltung

Katsuya Nakashima, Shumpei Kohri, Akira Nakagawara, 1993 .

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.

Derek Stephens, Barbara Hero, Samuel L Volchenboum, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Frank Speleman, Rogier Versteeg, Isabelle Janoueix-Lerosey, 2010, Clinical Cancer Research.

LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.

Miki Ohira, Akira Nakagawara, M. Ohira, 2005, Cancer research.

UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.

Akira Nakagawara, A. Nakagawara, T. Ozaki, 2003, Cancer research.

p53: The Attractive Tumor Suppressor in the Cancer Research Field

Akira Nakagawara, A. Nakagawara, T. Ozaki, 2010, Journal of biomedicine & biotechnology.

NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo.

Yusuke Suenaga, Akira Nakagawara, Yohko Nakamura, 2012, Cancer research.

Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.

Miki Ohira, Hideki Kimura, Soichiro Ando, 2006, Oncology reports.

Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation*

Akira Nakagawara, A. Nakagawara, T. Ozaki, 2004, Journal of Biological Chemistry.

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Roland Eils, Gudrun Schleiermacher, Barbara Hero, 2014, Clinical Cancer Research.

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

Chikashi Ishioka, Akira Nakagawara, Ryunosuke Kanamaru, 1998, Nature Medicine.

PPM1D is a potential target for 17q gain in neuroblastoma.

Akira Nakagawara, J. Inazawa, A. Nakagawara, 2003, Cancer research.

Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line

Yoshiyuki Sakaki, Masahira Hattori, Misao Ohki, 2000, Oncogene.

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Gudrun Schleiermacher, John M. Maris, Benedikt Brors, 2010, Clinical Cancer Research.

MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells.

Natsumi Kubo, Akira Nakagawara, A. Nakagawara, 2010, Biochemical and biophysical research communications.

Role ofsurvivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform,survivin-?/2B

Akira Nakagawara, A. Nakagawara, Y. Kaneko, 2000 .

Overlapping Roles for Homeodomain-Interacting Protein Kinases Hipk1 and Hipk2 in the Mediation of Cell Growth in Response to Morphogenetic and Genotoxic Signals

Haruhiko Koseki, Kazumi Nemoto, Akira Nakagawara, 2006, Molecular and Cellular Biology.

Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.

Miki Ohira, Akira Nakagawara, M. Ohira, 2004, Cancer letters.

Autoinhibitory Regulation of p73 by ΔNp73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the ΔNp73 Promoter

Takao Hayakawa, Hiroyuki Mizuguchi, Takahito Nakagawa, 2002, Molecular and Cellular Biology.

LMO3 interacts with p53 and inhibits its transcriptional activity.

Tomoki Yokochi, Akira Nakagawara, Yohko Nakamura, 2010, Biochemical and biophysical research communications.

p73: Structure and function

Akira Nakagawara, A. Nakagawara, M. Satoh, 2000, Pathology international.

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Gudrun Schleiermacher, Frank Berthold, Samuel L Volchenboum, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.